Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Thomas John

Medical Oncologist

Peter MacCallum Cancer Institute

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Articles (20)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (23)

Bronwen Connolly

The Queen's University Belfast

UNITED KINGDOM

View details

Suresh Ramalingam

Professor, Director of Medical Oncology

Emory University

UNITED STATES

View details

Sarah-Jane Dawson

Medical Oncologist and Group Leader

Peter MacCallum Cancer Institute

AUSTRALIA

View details

Ji-Youn Han

National Cancer Center

SOUTH KOREA

View details

David Carbone

Ohio State University Medical Center

UNITED STATES

View details

Terufumi Kato

Chief Physician

Kanagawa Cancer Center

JAPAN

View details

Adam Lee

Bristol-Myers Squibb

UNITED KINGDOM

View details

Wendy A Cooper

AUSTRALIA

View details

Tarek Meniawy

University of Western Australia

AUSTRALIA

View details

Jonathan W. Goldman

Associate Professor

UCLA

UNITED STATES

View details

Pilar Garrido López

Head Medical Oncology Department

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

SPAIN

View details

Lauren Gray

New South Wales Department of Planning and Environment

AUSTRALIA

View details

Marliese Alexander

Deputy Director of Pharmacy (Quality and Research)

Peter MacCallum Cancer Institute

AUSTRALIA

View details

David Adams

Senior Group Leader (and Interim Programme Head)

Wellcome Sanger Institute

UNITED KINGDOM

View details

Linda Denehy

Professor

University of Melbourne

AUSTRALIA

View details

Hossein Borghaei

Professor and Chief, Thoracic Oncology

Fox Chase Cancer Center

UNITED STATES

View details

Chris Brown

Senior Research Fellow Biostatistics

University of Sydney

AUSTRALIA

View details

Karen Trapani

University of Melbourne

AUSTRALIA

View details

Jill Francis

Professor of Implementation Science

University of Melbourne

AUSTRALIA

View details

Catherine Granger

Professor

University of Melbourne

AUSTRALIA

View details

Benjamin Solomon

Professor

University of Melbourne

AUSTRALIA

View details

Sarah (Sally) J Lord

Principal Research Fellow

University of Sydney

AUSTRALIA

View details

Chee Khoon Lee

Professor of Oncology

University of Sydney

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas John

Research Interests

Explore related searches

Articles (20)

Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancer

Clinical Impact of Somatic Genomic Variants of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced Non-Small Cell Lung Cancer.

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB–IIIA non-small-cell lung cancer

Updated efficacy and safety of entrectinib in <i>NTRK</i> fusion-positive non-small cell lung cancer

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial

A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE

Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma—RIOMeso

Lurbinectedin in small cell lung cancer: real‐world experience of a multicentre national early access programme

The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancer.

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

Therapeutic misunderstandings in modern research

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial

Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial

Rehabilitation outcomes for people with lung cancer (UNITE): protocol for the development of a core outcome set

A tailored approach to horizon scanning for cancer medicines

Breathing in danger: how particulate matter pollution is putting the public at risk of lung cancer†

LASERing FLAURAL Arrangements in Asian EGFR Subsets

Predicting response to immune checkpoint blockade in NSCLC with tumour-only RNA-seq

Collaborators (23)

Bronwen Connolly

Suresh Ramalingam

Sarah-Jane Dawson

Ji-Youn Han

David Carbone

Terufumi Kato

Adam Lee

Wendy A Cooper

Tarek Meniawy

Jonathan W. Goldman

Pilar Garrido López

Lauren Gray

Marliese Alexander

David Adams

Linda Denehy

Hossein Borghaei

Chris Brown

Karen Trapani

Jill Francis

Catherine Granger

Benjamin Solomon

Sarah (Sally) J Lord

Chee Khoon Lee

Make your next move.